Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Spring Sale
Enjoy this offer
* See conditions under "Our services"

Valuation: Eris Lifesciences Limited

Capitalization 19TCr 202.68Cr 175.14Cr 158.12Cr 151.22Cr 275.63Cr 283.39Cr 1.87TCr 745.03Cr 8.94TCr 760.5Cr 744.49Cr 32TCr P/E ratio 2026 *
37.5x
P/E ratio 2027 * 27.1x
Enterprise value 21TCr 224.36Cr 193.87Cr 175.03Cr 167.39Cr 305.11Cr 313.7Cr 2.07TCr 824.72Cr 9.89TCr 841.84Cr 824.11Cr 36TCr EV / Sales 2026 *
6.47x
EV / Sales 2027 * 5.33x
Free-Float
27.81%
Yield 2026 *
0.38%
Yield 2027 * 0.57%
1 day-0.13%
1 week-0.82%
Current month-0.66%
1 month-7.92%
3 months-16.15%
6 months-21.26%
Current year-10.38%
1 week 1,300.6
Extreme 1300.6
1,375.9
1 month 1,300.6
Extreme 1300.6
1,529
Current year 1,300.6
Extreme 1300.6
1,563
1 year 1,097.2
Extreme 1097.2
1,910
3 years 551.3
Extreme 551.3
1,910
5 years 551.3
Extreme 551.3
1,910
10 years 321
Extreme 321
1,910
Manager TitleAgeSince
Chief Executive Officer 52 27/01/2007
Director of Finance/CFO 46 28/09/2016
Chief Tech/Sci/R&D Officer - 01/05/2010
Director TitleAgeSince
Chairman 52 27/01/2007
Director/Board Member 54 27/01/2007
Director/Board Member 46 30/04/2018
Change 5d. change 1-year change 3-years change Capi.($)
-0.13%-0.82%+6.10%+120.64% 203.77Cr
-0.15%-0.78%+20.50%+217.39% 89TCr
-0.30%-1.52%+44.90%+60.27% 59TCr
+0.30%-2.64%+5.09%+52.08% 40TCr
-1.55%-7.15%+7.35%+25.17% 35TCr
-0.62%-4.08%+19.59%+62.48% 30TCr
-1.16%-3.00%+22.31%+35.39% 31TCr
-0.75%-3.02%+22.03%+7.91% 29TCr
+0.59%+0.17%+15.36%+65.73% 20TCr
-1.72%-1.24%+24.56%+83.65% 18TCr
Average -0.53%-1.87%+18.78%+73.07% 35.12TCr
Weighted average by Cap. -0.53%-1.91%+21.64%+91.18%

Financials

2026 *2027 *
Net sales 3.2TCr 35Cr 30Cr 27Cr 26Cr 47Cr 49Cr 320.01Cr 127.56Cr 1.53TCr 130.21Cr 127.47Cr 5.51TCr 3.73TCr 40Cr 35Cr 32Cr 30Cr 55Cr 57Cr 372.88Cr 148.64Cr 1.78TCr 151.72Cr 148.53Cr 6.42TCr
Net income 483.33Cr 5.24Cr 4.53Cr 4.09Cr 3.91Cr 7.13Cr 7.33Cr 48Cr 19Cr 231.1Cr 20Cr 19Cr 832.41Cr 684.57Cr 7.42Cr 6.41Cr 5.79Cr 5.54Cr 10Cr 10Cr 68Cr 27Cr 327.32Cr 28Cr 27Cr 1.18TCr
Net Debt 2TCr 22Cr 19Cr 17Cr 16Cr 29Cr 30Cr 199.9Cr 80Cr 955.84Cr 81Cr 80Cr 3.44TCr 1.19TCr 13Cr 11Cr 10Cr 9.59Cr 17Cr 18Cr 118.56Cr 47Cr 566.91Cr 48Cr 47Cr 2.04TCr
Logo Eris Lifesciences Limited
Eris Lifesciences Limited is an India-based pharmaceutical company. The Company is engaged in the manufacture and marketing of pharmaceutical products. The Company has a presence in major therapies like oral anti-diabetes, insulins, cardiovascular, vitamins/minerals and dermatology. Its flagship therapies include oral anti-diabetes, cardiovascular disease (CVD) and vitamins, minerals and nutrients (VMN). Its emerging therapies consist of dermatology, insulins, women’s health, central nervous system (CNS), oncology and nephrology. Its portfolio of brands includes Glimisave, Eritel, LNBloc, Olmin, Crevast, Atorsave, Gluxit, Renerve, Zomelis, Cosvate, Tayo, Cyblex, Remylin, Tendia, Rabonik, Ginkocer, Psorid, Raricap, Serlift, and Onabet, among others. Its patient care initiatives (PCI) platform provides various healthcare solutions to its patients. The Company has a manufacturing plant located in Guwahati, Assam.
Employees
3,354
Date Price Change Volume
11/26/11 1,349.30 -0.13% 35,750
10/26/10 1,351.10 +1.71% 1,00,690
09/26/09 1,328.40 -2.37% 47,652
06/26/06 1,360.70 -0.69% 19,895
05/26/05 1,370.20 +0.89% 34,594
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
1,349.30INR
Average target price
1,743.60INR
Spread / Average Target
+29.22%

Quarterly revenue - Rate of surprise

SPRING SALE -40%: The Best Tools Reserved for Subscribers to Identify Tomorrow's Top Investments!
d
:
:
BENEFIT NOW